Loading…
← CockpitCompetitor Analysis › 301557.SZ Cytech Group Co., Ltd. Class AOpen in the cockpit ↗

Cytech Group Co., Ltd. Class A301557.SZCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Specialty
Momentum leader 91
Mkt cap
$619M
US dollars, full cap
$/day
$9.86M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
+0.6 pp
WACC 7.1%
Hurdle
n/a
no reverse DCF
Close · CNYCN¥80.18
1D+1.6%
1W+4.0%
1M+7.7%
3M-0.5%
6M-0.5%
YTD-14.2%
1Y+22.6%
ATR %4.0%
52w lowhigh29.3% off high

What Cytech does

Employees: 1,294

Cytech at a glance

Size Cytech (301557.SZ) is a China Materials company (Chemicals: Specialty) with a market value of $619M, the 3175th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥80.18 on 18 Nov 2026.

Performance Over six months the shares fell 0.5%, against -27.1% for the median peer and -20.0% for the China market (cap-weighted) — 6th highest of 20 in its peer set.

Growth Revenue grew 12.6% over the last twelve months (peer median +10.9%); the operating margin is 6.9% (peer median 7.2%).

Valuation It trades at 3.6× enterprise value to sales against a peer median of 2.0× (5th most expensive of 20).

Capital Return on invested capital runs 0.6 points above its cost of capital (7.1% WACC).

Relative performance

8010021 May 202621 Aug 202618 Nov 2026301557.SZ 99Peer median 70
Six months, rebased to 100: Cytech against the median of its 20 peers (local-currency closes).

Cytech financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥1.26BCN¥1.18BCN¥1.04BCN¥868MCN¥736M
Revenue growth—+13%+20%+18%—
Gross profitCN¥296MCN¥245MCN¥253MCN¥202MCN¥179M
EBITDAn/aCN¥182MCN¥202MCN¥157MCN¥149M
Net incomeCN¥70.9MCN¥88.9MCN¥105MCN¥82.6MCN¥87.5M
Free cash flow-CN¥220M-CN¥213M-CN¥52.0M-CN¥44.6MCN¥3.72M
Capital expenditureCN¥103MCN¥134MCN¥88.9MCN¥94.1MCN¥64.4M
Total debtCN¥609MCN¥534MCN¥379MCN¥346MCN¥192M

Quarterly statements and history in the cockpit →

Cytech competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+100%-20%0%+20%1709688733477041160040004028300478DQ301076688386WAGAIOLCP3007272465301395603822301557.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Cytech is the large dot.

Fundamentals: revenue growth against valuation

0%+50%+100%0×5×10×1709688733301688477041160040004028300758300478DQ301076688386IOLCP3007272465603212603822301557.SZRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Cytech is the large dot.

Cytech competitors and peer comparison

How Cytech compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Cytech against its 20 peers (data as of 18 Nov 2026)
Measure301557.SZPeer medianRank in peer set
1-month return+7.7%-7.2%2nd highest of 21
6-month return-0.5%-27.1%6th highest of 20
Distance from 52-week high-29.3%-51.1%7th highest of 21
Revenue growth (TTM)+12.6%+10.9%8th highest of 21
Operating margin6.9%7.2%10th lowest of 20
EV / Sales3.6×2.0×5th most expensive of 20
ROIC minus cost of capital+0.6 pp-2.8 pp5th highest of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Cytech 301557.SZChina$619M-1%+13%7%3.6×n/an/a
Formosan Union Chemical 1709.TWTaiwan$619M+159%+14%41%2.0×-17.9%+1.2%
Anhui Estone Materials Technology 688733.SSChina$622M-43%+52%-2%5.9×n/an/a
Hangzhou Grascent 301688.SZChina$613Mn/a+12%n/a3.6×42.9%n/a
Allied Supreme 4770.TWTaiwan$628M+22%-5%21%3.4×1.3%+12.4%
Dainichiseika Color & Chemicals Mfg.Co 4116.TJapan$610M+23%+5%8%0.7×1.8%-2.1%
LOTTE Fine Chem 004000.KSSouth Korea$610M-45%+18%7%0.2×-20.1%+6.8%
Ishihara Sangyo Kaisha 4028.TJapan$631M-7%+3%10%0.8×2.1%+8.8%
Anshan Hifichem 300758.SZChina$631M-26%+11%9%3.1×16.0%+8.2%
Jiangsu Baichuan High-Tech New Materials 002455.SZChina$604M-43%+9%1%1.6×n/an/a
Hangzhou Gaoxin Materials Technology 300478.SZChina$600M-21%-21%-9%12.0×29.9%-0.9%
Daqo New Energy Corp Sponsored ADR DQUnited States$639M-46%-21%-70%0.6×n/an/a
Sino-High (China) 301076.SZChina$640M-43%+10%13%7.3×34.0%+9.1%
Pan Asian Microvent Tech (Jiangsu) 688386.SSChina$598M-50%+12%15%5.9×n/an/a
Waga Energy WAGA.PAFrance$642M-3%+7%-20%n/an/an/a
IOL Chemicals & Pharmaceuticals IOLCP.NSIndia$596M+72%+27%10%2.0×27.1%+3.5%
Ningbo Runhe High-Tech Materials 300727.SZChina$648M-38%+18%5%2.6×32.2%+14.6%
Jiangsu Lopal Tech 2465.HKHong Kong$590M-61%+107%7%0.9×n/an/a
Cybrid Technologies 603212.SSChina$588M-40%-9%-7%1.8×n/an/a
Renxin New Material 301395.SZChina$587M+13%+1%-6%1.8×n/an/a
Zhejiang Jiaao Enprotech Stock 603822.SSChina$585M-27%+101%19%1.5×-9.8%+31.6%

Questions

Which companies are Cytech's closest peers?
The cockpit's peer set: Formosan Union Chemical (1709.TW), Anhui Estone Materials Technology (688733.SS), Hangzhou Grascent (301688.SZ), Allied Supreme (4770.TW), Dainichiseika Color & Chemicals Mfg.Co (4116.T), LOTTE Fine Chem (004000.KS), Ishihara Sangyo Kaisha (4028.T), Anshan Hifichem (300758.SZ).
Is Cytech expensive compared with its peers?
On ev / sales it trades at 3.6× against a peer median of 2.0×, 5th most expensive of 20 in its peer set.
How has Cytech stock performed?
Over six months to 18 Nov 2026 the shares returned -0.5% against -27.1% for the median peer; over one year +22.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.